☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Telix
Telix Reports the Acquisition of ARTMS and its Advanced Isotope Production Platform
March 5, 2024
Telix to Acquire QSAM Biosciences to Enhance its Oncology Segment
February 8, 2024
Telix Reports the First Patient Dosing of TLX101 in P-I Study (IPAX-2) for Newly Diagnosed Glioblastoma
August 8, 2023
Telix Presented P-III Results from TLX250-CDx for Kidney Cancer Imaging Study at the ASCO GU 2023
February 20, 2023
Telix Reports the First Patient Dosing of TLX101 in P-II (IPAX-Linz) Study for the Treatment of Glioblastoma
November 22, 2022
Telix Reports the Completion of Patient Enrollment in P-III (ZIRCON) Study of TLX250-CDx for the Treatment of Clear Cell Renal Cel...
July 11, 2022
Load more...
Back to Home